Ashkenazi Jews

(redirected from Askanazi)
Also found in: Wikipedia.

Ashkenazi Jews

In the 11th century, Ashkenazi Jews comprised 3% of the world's Jewish population, peaking at 92% in 1931; following the holocaust in World War II, that number decreased. Ashkenazi Jews now comprise ±80% of Jews worldwide.

Carrier rates, genetic diseases affecting Ashkenazi Jews
• Factor XI deficiency—1:9 to 1:20
• Gaucher disease, type 1—1:10 to 1:14
• Non-syndrome hearing loss—1:20 to 1:25
• Tay-Sachs disease—1:25 to 1:27
• Cystic fibrosis—1:29
• Familial dysautonomia—1:30
• Glycogen storage disease type III—1:35 (north African Jews)
• Canavan disease—1:40
• BRCA1, BRCA2—1:40
• Fanconi anaemia, type C—1:89
• Niemann-Pick disease, type A—1:90
• Mucolipidosis IV—1:99
• Bloom syndrome—1:110
• Maple syrup urine disease—1:113
• Glycogen storage disease type 1a—1:130
• Abetalipoproteinemia—1:131
• Primary torsion dystonia—1:1000 to 1:3000
References in periodicals archive ?
Jeff Askanazi, Harold Buttram, Emanuel Cheraskin, Patrick Donovan, Elsie Ferguson, Carl Franzblau, Alan Gaby, Leo Galland, William Harris, Richard Huemer, Robert Leichtman, Henry Liers, Jon Pangborn, Ed Smith, Robert Soll, Dana Ullman, Vincent Speckhart, Mel Werbach, Jon Wright, and Steve Zekan are gratefully acknowledged.
Askanazi had both billed for unnecessary services and provided those services in a grossly negligent matter, finding him guilty on 33 counts of billing fraud.
In the Askanazi case and others like it that involve distinct procedures, the quality of care issue can be defined narrowly.
People with disabilities are plagued with a plethora of secondary disabilities and illnesses (Frank, Umlauf, Wonderlich, Askanazi, Buclelew, & Elliot, 1987; Kerr, 1977; Miller, 2000; Trieschmann, 1987; Vash, 1994; Wright, 1983).
Insel J, Weissman c, Kemper M, Askanazi J, Hyman AI: Cardiovascular changes during transport of critically ill and postoperative patients.
Jeffrey Askanazi, VP and Scientific Director, the company has filed with the FDA a Commercial IND for "PERTHON", and all natural herbal product that provides new hope to enhance the human immune system in treating HIV and AIDS patients.
Jeff Askanazi, Harold Buttram, Emanuel Cheraskin, Patrick Donovan, Elsie Ferguson, Cari Franzblau, Alan Gaby, Leo Galland, William Harris, Richard Huemer, Robert Leichtman, Henry Liers, Jon Pangborn, Ed Smith, Robert Soll, Dana Ullman, Vincent Speckhart, Mel Werbach, Jon Wright, and Steve Zekan are gratefully acknowledged.
Support for this funding has been demonstrated by previous rehabilitation research (Trieschman, 1987; Frank & Elliott, 1987; Frank, Umlauf, Wonderlich, Askanazi, Buckelew & Elliott, 1987), which has shown that there appears to be a direct relationship between improved personal adjustment and positive rehabilitation outcomes, such as one's ability to function appropriately in society after the occurrence of disability.